Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
NeuroCycle Therapeutics, Inc. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $720,182 in 2019. These are non-dilutive federal research grants, not equity financing. The company is based in Cambridge, Massachusetts.
No investors recorded yet for NeuroCycle Therapeutics, Inc..
Add an investorNeuroCycle Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for NeuroCycle Therapeutics, Inc..
Add diversity data